POLYCYSTIC OVARY SYNDROME (PCOS) is a common heterogeneous disorder, where insulin resistance might be involved in the development of endocrine and metabolic abnormalities [1]. It affects about 5 -10% of reproductive-aged women and increases the risk of reproductive abnormalities [2, 3]. PCOS women have an enlarged prevalence of obesity and obese as well as lean are more insulin-resistant and hyperinsulinemic than age-and weight-matched normal women [3][4][5]. Incidence of insulin resistance occurs in approximately 50-95% of women with PCOS [6, 7]. In this condition, the mechanisms of insulin resistance has not Normal metabolic flexibility despite insulin resistance women with polycystic ovary syndrome ), and 30 healthy normally menstruating women (14 lean and 16 overweight/ obese) with normal glucose tolerance. Hyperinsulinemic euglycemic clamp and indirect calorimetry were performed. An increase in respiratory exchange ratio in response to insulin was used as a measure of metabolic flexibility. Both the presence of PCOS (P<0.001) and obesity (P=0.005) were independently characterized by lower insulin sensitivity. PCOS (P=0.002) and obesity (P=0.001) independently predisposed to the lower non-oxidative glucose metabolism. Obese women had lower glucose oxidation (P=0.005) and higher lipid oxidation (P<0.001) in insulin-stimulated conditions in comparison to lean subject whereas PCOS had no effect on these parameters (P=0.29 and P=0.43; respectively). Metabolic flexibility was impaired in the obese (P=0.001) but it was not influenced by the presence of PCOS (P=0.78). Our data indicate that PCOS women have normal metabolic flexibility, which could suggest a distinct pathophysiological mechanism for insulin resistance in this group.
been clear established and could be distinct from this observed in type 2 diabetes and obesity. Rodin et al. showed that the effects of type 2 diabetes mellitus and PCOS on insulin resistance were independent of each other [8] .
Metabolic flexibility (MF) is characterized by increased fat oxidation in skeletal muscle during fasting conditions and the ability to switch from fat to carbohydrate oxidation in response to insulin [9] . Insulin resistance is connected with disturbances in switching between lipid and carbohydrate oxidation in response to insulin, and it is called "metabolic inflexibility" [9] . Lower MF was observed in obese non-diabetic individuals [10, 11] , patients with type 2 diabetes mellitus and with a family history of type 2 diabetes mellitus [12] . In skeletal muscle glucose might be either oxidized or stored as glycogen in response to insulin. The non-oxidative glucose metabolism (NOGM) smokers. Studies were performed in the PCOS group 3-5 days after a spontaneous menses or independent of cycle phase in the presence of amenorrhea and in regularly cycling women during the early follicular phase (3-5 days) of their menstrual cycle. All analyses were performed after an overnight fast. Before entering the study, physical examination were performed. All subjects underwent an oral glucose tolerance test (OGTT) and had normal glucose tolerance according to WHO criteria. All subjects gave written informed consent before entering the study. The study protocol was approved by the Ethics Committee of Medical University of Bialystok, Poland.
Anthropometric measurements
BMI was calculated as body weight in kilograms divided by height in meters squared (kg/m 2 ). The waist circumference was measured at the smallest circumference between the rib cage and the iliac crest, with the subject in the standing position. Percent of body fat was estimated by bioelectric impedance analysis using the Tanita TBF-511 Body Fat Analyzer (Tanita Corp., Tokyo, Japan).
Insulin sensitivity
Insulin sensitivity was evaluated by the euglycemic hyperinsulinemic clamp technique according to DeFronzo et al. [21] , as described previously [4-5, 10, 17, 22] . Insulin (Actrapid HM, Novo Nordisk, Copenhagen, Denmark) was given as a primed-continuous intravenous infusion for 2 hours at 40 mU x m -2 x min -1 , resulting in constant hyperinsulinemia of approximately 75 mIU/L. Arterialized blood glucose was obtained every 5 minutes and 20% dextrose (1.11 mol/L) infusion was adjusted to maintain plasma glucose levels at 5.0 mmol/L. The glucose infusion rate approached stable values during final 40 minutes of the study and the rate of whole-body glucose uptake (M value) was calculated as the mean glucose infusion rate from 80 to 120 min, corrected for glucose space and normalized per kilogram of fat-free mass (M ffm ).
Lipid and carbohydrate oxidation
Whole-body lipid and carbohydrate oxidation rates were measured by indirect calorimetry using the ventilated hood technique (Oxycon Pro, Viasys Healthcare GmbH -Erich Jaeger, Hochberg, Germany) in order to calculate substrate oxidation from respiratory gas exchange (oxygen consumption and carbon dioxide represents more than 90% accumulation of glucose as glycogen in muscle [13] . Substrate metabolism could be altered in women with PCOS. The available data are not consistent which fluctuation in substrate metabolism are predominant. Some data showed that impaired insulin-stimulated oxidative glucose disposal was observed in PCOS patients compared with control subjects [14, 15] , others confirmed that non-oxidative glucose metabolism is changed [15] [16] [17] [18] whereas Eriksen et al. did not observed defects in insulin-stimulated glycogen synthase activity [19] . Højlund and co-workers showed that insulin-stimulated glucose disposal was 50% lower in PCOS women than in control subjects, and this was primarily accounted for by a 60% reduction in non-oxidative glucose disposal but also a 39% decrease in glucose oxidation [18] . In this study higher fat oxidation in hyperinsulinemia in obese PCOS group was also detected [18] . There are also data demonstrated that lipid uptake and oxidation did not differ between PCO and control women [15, 17] although our group recently published an observation that variant of the FTO gene affects basal lipid oxidation in PCOS women [17] .
The aim of the present study was to estimate the whole-body insulin sensitivity, lipid and carbohydrate oxidation, metabolic flexibility in lean and obese PCOS women.
Subjects and Methods

Subjects
We examined 92 women with PCOS, 40 lean (BMI<25 kg/m 2 ) and 52 with overweight or obesity (BMI>25kg/m 2 ), and 30 healthy normally menstruating women (14 lean and 16 overweight or obese, control group). The diagnosis of PCOS was made according to the 2003 Rotterdam ESHRE/ASRM PCOS Consensus Workshop Group diagnostic criteria [20] and was described in detail previously [4] . Patients were recruited from the outpatient clinic of the Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok and from the medical staff and students. Control subjects were recruited from the medical staff and students. All participants had no morbid obesity, cardiovascular disease, hypertension, infections and other serious medical problems and were not taking anti-inflammatory drugs (within previous 3 months) or any drugs known to affect glucose and lipid metabolism, all were non-estimated with factorial ANOVA, with PCOS status and obesity as a categorical factors and the studied parameters as dependent variables. Factorial ANOVA enabled us to estimate the effect of both obesity and PCOS status and also to study the interaction between both these conditions. Post-hoc Scheffe's test was applied when we found significant interaction. The level of significance was accepted at P< 0.05.
Results
The clinical characteristics of the studied groups are shown in Table 1 . The PCOS lean and obese group did not differ from the lean and obese control group in age and BMI. Both the presence of PCOS and obesity were independently characterized by lower insulin sensitivity (P<0.001 and P=0.005, respectively; P=0.55 for the interaction) ( Table 1 ). The interaction between PCOS status and obesity was not significant which suggests that decreased of insulin sensitivity in PCOS was independent of obesity and the effect of obesity was independent of PCOS.
PCOS women had lower NOGM than the control group (P=0.002). We also found that obese subjects had lower NOGM than the lean women (P=0.001) ( Table 2) . We did not observe interaction between PCOS status and obesity (P=0.71).
Obese women had lower glucose oxidation (P=0.005) and higher lipid oxidation (P<0.001) in insulin-stimulated conditions in comparison to lean subjects whereas PCOS had no effect on these parameters (P=0.29, P=0.43; respectively) ( Table 2 ). Obesity had influence on the rate of lipid oxidation during the clamp (P<0.001). This effect was dependent on the presence of PCOS (P=0.03 for the interaction between obesity and PCOS). In post-hoc analysis we found that the rate of lipid oxidation during the clamp in obese subjects without PCOS was significantly higher in comparison to lean subjects without PCOS (P=0.006), whereas such difference was not observed in PCOS subjects.
Metabolic flexibility did not differ between PCOS and control subjects whereas it was decreased in the obese group compared with the lean group (P=0.78, P=0.001; respectively) ( Table 2) . We did not observe interaction between PCOS status and obesity (P=0.33).
We observed that obesity had influence on RER during the clamp (P=0.0003). PCOS status had no impact on RER during hyperinsulinemia (P=0.52) but there were significant interaction between PCOS status and production), as described previously [10, 17, 22] . The device was calibrated before each test using reference gases. Measurements were performed while the subjects were lying in a supine position at baseline (in the fasting state) and during the last 30 minutes of the clamp study. Each study was performed in the thermoneutral environment, after relaxed 15 minutes. NOGM was calculated by subtracting the carbohydrates oxidation rate during hyperinsulinemia from whole-body glucose disposal rate. An increase in respiratory exchange ratio in response to insulin was used as a measure of metabolic flexibility.
Biochemical analyses
Fasting blood samples were taken from the antecubital vein before the beginning of the clamp for the determination of serum lipids and hormones. Samples were frozen at -80°C until analyses. Plasma glucose was measured immediately by the enzymatic method using glucose analyzer (YSI 2300 STAT PLUS). Serum insulin was measured with the monoclonal immunoradiometric assay (IRMA, Medgenix Diagnostics, Fleunes, Belgium). The minimum detectable concentration was 1 µIU/mL and the intra-assay and inter-assay coefficients of variation (CVs) were below 2.2 % and 6.5 %, respectively. In that method, human and animal proinsulins present no cross-reaction. Serum total and HDLcholesterol and triglycerides (TG) were assessed by the enzymatic methods using commercial kits produced by ANALCO-GBG, Poland. Serum luteinizing hormone, follicle-stimulating hormone, testosterone, and oestradiol were measured by the chemiluminescence method (ACS Chirone 180), and serum sex hormone-binding globulin (SHBG) was measured by the immunoradiometric assay (ZenTech, Angleur, Belgium). The sensitivity and CVs for all these assays were identical, as reported previously [4] . Free androgen index was calculated as serum testosterone (nmol/L) × 100/SHBG (nmol/L) ratio [23] .
Statistical analysis
The statistics were performed with STATISTICA 9.0 software. The variables, which did not have normal distribution (fasting and postload insulin, triglycerides, SHBG, testosterone, free androgen index, oestradiol, substrate oxidation) were log-transformed prior to analyses. For the purpose of the data presentation, these variables were transformed to absolute values in the Results. The differences between the groups were Data are presented as mean ± SD. P values are derived from factorial ANOVA. All interactions between PCOS status and obesity are nonsignificant. L, lean; O, obese; Cont., Control; BMI, body mass index; postload glucose and insulin refer to value at 120 min of the oral glucose tolerance test; TG, triglycerides; M ffm , whole-body glucose uptake normalized per kg of fat-free mass; NS, not significant . We found that PCOS women were characterized only by decreased non-oxidative glucose metabolism whereas glucose and lipid oxidation before and during the hyperinsulinemic normoglycemic clamp were preserved. It could mean that the mechanism of insulin resistance is selectively connected with NOGM in PCOS women. Disturbances in NOGM were observed previously in this group [15] [16] [17] [18] 24] . In cultured fibroblasts from PCOS patients, impaired insulin action on glycogen synthesis was associated with increased basal insulin receptor Ser phosphorylation and decreased insulin-stimulated insulin receptor Tyr phosphorylation [24, 25] whereas IRS-1-associated PI3K activity and mitogenic action of insulin were undamaged [24] . Therefore, our results indicate that only a non-oxidative pathway of glucose metabolism is resistant to the action of insulin in PCOS. On the other hand, Eriksen et al. found no evidence for defects in insulin-stimulated glycogen synthesis in PCOS group [19] whereas Hojlund et al. showed not only reduction of non-oxidative glucose metabolism, but also decrease in glucose oxidation in insulin resistance PCOS women [18] . The difference in obtained results can be explained by the discrepancy in the characteristic of the PCOS groups.
Højlund et al. studied PCOS women who were more obese (mean BMI, 33.7 kg/m 2 ) than our PCOS group. The other explanation for conflicting data could be partly connected with heterogenecity in PCOS women, obesity (P=0.01) ( Table 2) . RER during the clamp in obese patient without PCOS was significantly lower in comparison to lean patient without PCOS.
PCOS women had higher serum luteinizing hormone, testosterone concentrations and free androgen index in comparison to control group (all P < 0.0001) ( Table 3) .
We performed the multivariate logistic analysis to exclude the effects of confounding factors and we observed that the relationships of NOGM with PCOS status (β=0.17; P=0.01) and BMI (β=-0.41; P=0.004) were independent of each other and independent of age, percent of body fat, waist circumference, fasting glucose and insulin concentration, insulin sensitivity, triglycerides and RER during the clamp.
Discussion
Our results demonstrated, for the first time, that women affected by PCOS have preserved metabolic flexibility in spite of decreased of insulin sensitivity. In our study both the presence of PCOS and obesity were independently characterized by lower insulin sensitivity but obese subject were characterized by decreased of metabolic flexibility. In the obese group carbohydrate oxidation was lower and lipid oxidation was higher in insulin-stimulated conditions, moreover this group have decreased non-oxidative glucose metabolism. We demonstrated that obesity had influence on the rate of lipid oxidation during the clamp whereas PCOS status had no impact on lipid oxida- cose oxidation and higher lipid oxidation in insulinstimulated conditions which are responsible for metabolic inflexibility in this state. The mechanism of insulin resistance is selectively connected with NOGM in PCOS women and probably it could be the first step of development of insulin resistance.
In conclusion, we observed that lean and obese PCOS women have normal metabolic flexibility because of preserved response in glucose and lipid oxidation to insulin whereas impairment insulin sensitivity were selectively connected with decreased of non-oxidative glucose metabolism.
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ethnic variations and also prevalence of a positive family history of type 2 diabetes.
In insulin resistance there is defective suppression of the rate of lipid oxidation in response to insulin. Some researchers observed higher fat oxidation in hyperinsulinemic state in obese PCOS women [26] but also there are data demonstrated that lipid uptake and oxidation did not differ between PCO and control group [19] like in our results. We previously published that variant of the FTO gene affects basal lipid oxidation in PCOS women and this effect was independent of obesity [17] . It could be connected with variety of phenotypes in PCOS women.
The reason of difference in obtained results in substrate metabolism could be diverse response in skeletal muscle and adipose tissue to insulin in insulin resistance state in PCOS. We assessed oxidative glucose and lipid metabolism and non-oxidative glucose metabolism in whole body not in particular tissues.
PCOS and obese group were characterized by lower insulin sensitivity whereas PCOS women had preserved metabolic flexibility and decreased NOGM. Obese women had lower not only NOGM but also glu-
